STOCK TITAN

OPKO Health (OPK) CFO sees 53,266 shares withheld to cover taxes

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

OPKO Health, Inc. reported that Sr. Vice President and CFO Adam Logal had 53,266 shares of common stock withheld on July 24, 2026 at $1.22 per share to satisfy tax withholding on vesting of restricted stock units. After this tax-withholding disposition, he directly owns 563,396 shares.

Positive

  • None.

Negative

  • None.
Insider Logal Adam
Role Sr. Vice President, CFO
Type Security Shares Price Value
Tax Withholding Common Stock F1 53,266 $1.22 $65K
Holdings After Transaction: Common Stock — 563,396 shares (Direct)
Footnotes (1)
  1. F1. This number represents shares of common stock par value $0.01 per shares of OPKO Health, Inc. withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
Shares withheld for taxes 53,266 shares Common Stock withheld on 2026-07-24 to satisfy tax withholding obligation upon RSU vesting
Imputed share price for withholding $1.22 per share Value used for the tax-withholding disposition on 2026-07-24
Post-transaction direct holdings 563,396 shares Common Stock directly held by Adam Logal after the tax-withholding transaction
restricted stock units financial
"due upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligation financial
"withheld to satisfy the tax withholding obligation due"
tax-withholding disposition financial
"transaction_action: tax-withholding disposition in Common Stock"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transaction did OPKO Health (OPK) CFO Adam Logal report?

Adam Logal, Sr. Vice President and CFO of OPKO Health (OPK), reported 53,266 shares of common stock withheld at $1.22 per share on July 24, 2026 to satisfy tax obligations upon vesting of restricted stock units, leaving 563,396 shares directly owned.

What does transaction code F mean in the OPKO Health (OPK) Form 4?

Transaction code F denotes a tax-withholding disposition, described as payment of tax liability by delivering or withholding securities. For OPKO Health (OPK) CFO Adam Logal, it reflects shares withheld to cover taxes triggered when his restricted stock units vested, rather than a standard buy-or-sell trade.

How many OPKO Health (OPK) shares does Adam Logal own after this transaction?

After the reported tax-withholding transaction, Adam Logal directly owns 563,396 shares of OPKO Health common stock. This figure represents his remaining direct holdings following the 53,266-share tax-withholding disposition dated July 24, 2026, as disclosed in the insider ownership detail.

Was Adam Logal’s OPKO Health (OPK) transaction made under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, meaning the reported tax-withholding disposition was not executed under a Rule 10b5-1 trading plan. It instead reflects shares withheld to satisfy tax obligations tied to restricted stock unit vesting.

Why were Adam Logal’s OPKO Health (OPK) shares withheld?

The 53,266 shares were withheld to satisfy Adam Logal’s tax withholding obligation arising when his OPKO Health restricted stock units vested. Instead of receiving all vested shares in stock, a portion was retained for taxes, leaving him with 563,396 shares directly owned.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Logal Adam

(Last)(First)(Middle)
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.

(Street)
MIAMI FLORIDA 33137

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
OPKO HEALTH, INC. [ OPK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Sr. Vice President, CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/24/2026F53,266(1)D$1.22563,396D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This number represents shares of common stock par value $0.01 per shares of OPKO Health, Inc. withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
Adam Logal07/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)